Abstract:Objective To evaluate the pharmacokinetic profiles and rel-ative bioavailability of fluvastatin in healthy Chinese subjects following o-ral administration of single and multiple doses of prolonged -extended re-lease ( XL) fluvastatin sodium tablets or immediate -release ( IR) cap-sules.Methods This was an open -label, randomized, two-period, two-treatment, crossover study.Twenty -four subjects were orally ad-ministered fluvastatin sodium XL tablet 80 mg qd or IR capsule 40 mg bid for 7 days.The serum concentrations of fluvastatin were determined by LC-MS/MS.The pharmacokinetic parameters and the relative bioavail-ability were calculated by non -compartmental analysis ( NCA ) using WinNonlin program.The statistical comparison of the pharmacokinetic parameters between these two formulations was conducted using SPSS 18.0.Results The pharmacokinetic parameters of fluvastatin after single oral dose of fluvastatin sodium XL tablet 80 mg qd and fluvastatin IR capsule 40 mg bid were as follows:Cmax were (79.00 ±36.83 ), (439.80 ±199.35 ) ng· mL-1;tmax were 3.00,0.50 h;t1/2 were (5.39 ± 2.89), (1.88 ±0.50) h;AUC0-24 h were (347.82 ±134.19 ), (815.25 ±326.30 ) ng· h· mL-1;AUC0-∞ were (342.34 ±146.05), (792.32 ±294.33) ng· h· mL -1, respectively.The pharmacokinetic parameters of fluvastatin after multiple oral doses of fluvastatin sodium XL tablet 80 mg qd and IR capsule 40 mg bid were as follows:Cmax,s were (96.85 ±59.38), (526.54 ±228.08) ng· mL-1;Cav,sswere (18.04 ±8.29), (63.39 ±29.02) ng· mL-1;tmax,ss were 3.00, 0.50 h;t1/2 were (5.13 ±2.69 ), (1.74 ±0.26 ) h; AUCtau,ss were (435.46 ±213.14 ), (1194.11 ± 582.51 ) ng· h· mL-1 , respectively.The relative bioavailabilities of fluvastatin sodium XL tablet 80 mg to IR capsule 40 mg were 43.94%and 38.67%on day 1 ( after single dose administration ) and day 7 ( after reaching steady state ) , respectively.Mild adverse events occurred in this trial.Conclusion Comparing with fluvastatin sodium IR capsues , Cmax of fluvastatin sodium XL tablet was reduced and tmax was prolonged.There was no significant accumulation for XL and IR formulations after multiple doses.

A Study of the Pharmacokinetics and Bioavailability of Sustained-release Lovastatin Capsules in Dogs

Study on Preparation of Levetiracetam Sodium Extended-release Tablet and It's Pharmacokinetics in Beagle Dogs

Study on bioequivalence of cilostazol table in healthy volunteers

Study on Correlation Between in vitro Release and in vivo Absorption of Captopril Delayed-onset, Sustained Release Tablet

Bioequivalence of Levodopa and Benserazide Hydrochloride Capsules in Beagle Dogs

Study on Correlation Between {\sl in Vitro} Release and {\sl in Vivo} Absorption of Captopril Delayed--onset, Sustained Release Tablet

Pharmacokinetics of Self-Microemulsifying Drug Delivery System of Simvastatin in Beagle Dogs

Plasma concentration of sibutramine hydrochloride in beagle dog assayed by LC-MS and study on its pharmacokinetics

Bioequivalence of two tablet formulations of cefpodoxime proxetil in beagle dogs

Bioavailability of Bicalutamide Tablets in Beagle Dogs

The investigation of the pharmacokinetics of pulsatile-release salbutamol sulfate with pH-sensitive ion exchange resin as the carriers in beagle dogs.

Study on Pharmacokinetics-Pharmacodynamics of Xinning Extended Action Tablet on Dogs

Preparation of Capsules Filled with Nicotinic Acid Sustained-release Particles and Simvastatin Particles

Self-made lovastatin/nicotinic acid sustained-release tablets and its pharmacokinetics in healthy volunteers

In Vitro and in Vivo Evaluation of Levofloxacin Sustained-Release Capsules.

HPLC assay and pharmacokinetic study of atorvastatin in beagle dogs after oral administration of atorvastatin self-microemulsifying drug delivery system.

Pharmacokinetics of piroxicam-β-cyclodextrin inclusion complexes in Beagle dogs

The Use of Systemically Absorbed Drugs to Explore An In Vitro Bioequivalence Approach For Comparing Non-Systemically Absorbed Active Pharmaceutical Ingredients in Drug Products For Use in Dogs

Preliminary Bioequivalence of an Oral Pimobendan Solution Formulation with Reference Solution Formulation in Beagle Dogs

Pharmacokinetics of Metronidazole Colon-Targeted Capsules in Dogs

Study on pharmacokinetics of fluvastatin in healthy subjects after single and multiple doses of porolonged-extended release fluvastatin and immediate-release fluvastatin